These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

367 related articles for article (PubMed ID: 26124093)

  • 21. Neutralizing the MERS coronavirus threat.
    Haagmans BL; Osterhaus AD
    Sci Transl Med; 2014 May; 6(235):235fs19. PubMed ID: 24807556
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prospects for a MERS-CoV spike vaccine.
    Zhou Y; Jiang S; Du L
    Expert Rev Vaccines; 2018 Aug; 17(8):677-686. PubMed ID: 30058403
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Epitope-Based Vaccine Target Screening against Highly Pathogenic MERS-CoV: An In Silico Approach Applied to Emerging Infectious Diseases.
    Shi J; Zhang J; Li S; Sun J; Teng Y; Wu M; Li J; Li Y; Hu N; Wang H; Hu Y
    PLoS One; 2015; 10(12):e0144475. PubMed ID: 26641892
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of Fc Fusion on Folding and Immunogenicity of Middle East Respiratory Syndrome Coronavirus Spike Protein.
    Chun J; Cho Y; Park KH; Choi H; Cho H; Lee HJ; Jang H; Kim KH; Oh YK; Kim YB
    J Microbiol Biotechnol; 2019 May; 29(5):813-819. PubMed ID: 30982320
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Receptor-binding domain of MERS-CoV with optimal immunogen dosage and immunization interval protects human transgenic mice from MERS-CoV infection.
    Wang Y; Tai W; Yang J; Zhao G; Sun S; Tseng CK; Jiang S; Zhou Y; Du L; Gao J
    Hum Vaccin Immunother; 2017 Jul; 13(7):1615-1624. PubMed ID: 28277821
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MERS-CoV spike protein: a key target for antivirals.
    Du L; Yang Y; Zhou Y; Lu L; Li F; Jiang S
    Expert Opin Ther Targets; 2017 Feb; 21(2):131-143. PubMed ID: 27936982
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Systemic and mucosal immunity in mice elicited by a single immunization with human adenovirus type 5 or 41 vector-based vaccines carrying the spike protein of Middle East respiratory syndrome coronavirus.
    Guo X; Deng Y; Chen H; Lan J; Wang W; Zou X; Hung T; Lu Z; Tan W
    Immunology; 2015 Aug; 145(4):476-84. PubMed ID: 25762305
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Progress of Middle East respiratory syndrome coronavirus vaccines: a patent review.
    Choi J; Kim MG; Oh YK; Kim YB
    Expert Opin Ther Pat; 2017 Jun; 27(6):721-731. PubMed ID: 28121202
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Generation of a transgenic mouse model of Middle East respiratory syndrome coronavirus infection and disease.
    Agrawal AS; Garron T; Tao X; Peng BH; Wakamiya M; Chan TS; Couch RB; Tseng CT
    J Virol; 2015 Apr; 89(7):3659-70. PubMed ID: 25589660
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mouse-adapted MERS coronavirus causes lethal lung disease in human DPP4 knockin mice.
    Li K; Wohlford-Lenane CL; Channappanavar R; Park JE; Earnest JT; Bair TB; Bates AM; Brogden KA; Flaherty HA; Gallagher T; Meyerholz DK; Perlman S; McCray PB
    Proc Natl Acad Sci U S A; 2017 Apr; 114(15):E3119-E3128. PubMed ID: 28348219
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Human Neutralizing Monoclonal Antibody Inhibition of Middle East Respiratory Syndrome Coronavirus Replication in the Common Marmoset.
    Chen Z; Bao L; Chen C; Zou T; Xue Y; Li F; Lv Q; Gu S; Gao X; Cui S; Wang J; Qin C; Jin Q
    J Infect Dis; 2017 Jun; 215(12):1807-1815. PubMed ID: 28472421
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antibody-mediated protection against MERS-CoV in the murine model.
    New RRC; Moore BD; Butcher W; Mahood R; Lever MS; Smither S; O'Brien L; Weller SA; Bayliss M; Gibson LCD; Macleod C; Bogus M; Harvey R; Almond N; Williamson ED
    Vaccine; 2019 Jul; 37(30):4094-4102. PubMed ID: 31178378
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Qualitative and Quantitative Determination of MERS-CoV S1-Specific Antibodies Using ELISA.
    Al-Amri SS; Hashem AM
    Methods Mol Biol; 2020; 2099():127-133. PubMed ID: 31883093
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An orthopoxvirus-based vaccine reduces virus excretion after MERS-CoV infection in dromedary camels.
    Haagmans BL; van den Brand JM; Raj VS; Volz A; Wohlsein P; Smits SL; Schipper D; Bestebroer TM; Okba N; Fux R; Bensaid A; Solanes Foz D; Kuiken T; Baumgärtner W; Segalés J; Sutter G; Osterhaus AD
    Science; 2016 Jan; 351(6268):77-81. PubMed ID: 26678878
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Characterization of a human monoclonal antibody generated from a B-cell specific for a prefusion-stabilized spike protein of Middle East respiratory syndrome coronavirus.
    Choi JH; Woo HM; Lee TY; Lee SY; Shim SM; Park WJ; Yang JS; Kim JA; Yun MR; Kim DW; Kim SS; Zhang Y; Shi W; Wang L; Graham BS; Mascola JR; Wang N; McLellan JS; Lee JY; Lee H
    PLoS One; 2020; 15(5):e0232757. PubMed ID: 32384116
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of an ideal adjuvant for receptor-binding domain-based subunit vaccines against Middle East respiratory syndrome coronavirus.
    Zhang N; Channappanavar R; Ma C; Wang L; Tang J; Garron T; Tao X; Tasneem S; Lu L; Tseng CT; Zhou Y; Perlman S; Jiang S; Du L
    Cell Mol Immunol; 2016 Mar; 13(2):180-90. PubMed ID: 25640653
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunogenicity of Candidate MERS-CoV DNA Vaccines Based on the Spike Protein.
    Al-Amri SS; Abbas AT; Siddiq LA; Alghamdi A; Sanki MA; Al-Muhanna MK; Alhabbab RY; Azhar EI; Li X; Hashem AM
    Sci Rep; 2017 Mar; 7():44875. PubMed ID: 28332568
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A novel human mAb (MERS-GD27) provides prophylactic and postexposure efficacy in MERS-CoV susceptible mice.
    Niu P; Zhao G; Deng Y; Sun S; Wang W; Zhou Y; Tan W
    Sci China Life Sci; 2018 Oct; 61(10):1280-1282. PubMed ID: 30091015
    [No Abstract]   [Full Text] [Related]  

  • 39. Development and characterization of three novel mouse monoclonal antibodies targeting spike protein S1 subunit of Middle East respiratory syndrome corona virus.
    Abbas AT; El-Kafrawy SA; Tabll AA; Hashem AM; Al Subhi TL; Alsaadi M; Azhar EI
    Hum Antibodies; 2024; 32(3):129-137. PubMed ID: 38758996
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A Human DPP4-Knockin Mouse's Susceptibility to Infection by Authentic and Pseudotyped MERS-CoV.
    Fan C; Wu X; Liu Q; Li Q; Liu S; Lu J; Yang Y; Cao Y; Huang W; Liang C; Ying T; Jiang S; Wang Y
    Viruses; 2018 Aug; 10(9):. PubMed ID: 30142928
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.